This inventor holds 1 USPTO granted patent. Top assignee: Neumora Therapeutics, Inc.. Active years: 2025.
Company Filing History:
Years Active: 2025
Title: The Innovative Contributions of John Chan
Introduction
John Chan is an accomplished inventor based in Boston, MA. He has made significant strides in the field of facial analysis technology. His work has the potential to impact various applications, from security to user experience enhancement.
Latest Patents
John Chan holds a patent for a groundbreaking invention titled "System and method of facial analysis." This system comprises a camera, a data storage device, and a data processing system. The camera captures video of a subject's face, while the data storage device receives and stores this video. The data processing system extracts the pose of the subject's face and a representation of the subject's facial gesture state. The pose includes the angle and position of the subject's face, and the representation consists of facial keypoints, which are a collection of points on the subject's face. The system aligns the data streams in time, extracts a plurality of facial syllables from the aligned data streams, and compiles these syllables into a series of state sequences. Based on these sequences, the system extracts a behavioral fingerprint for the subject, summarizing the subject's state over a given period of time. John Chan's innovative approach has resulted in 1 patent.
Career Highlights
John Chan is currently employed at Neumora Therapeutics, Inc., where he continues to develop and refine his innovative technologies. His work at Neumora Therapeutics focuses on advancing the understanding of facial analysis and its applications in various fields.
Collaborations
John has collaborated with notable colleagues, including Sandeep R Datta and Alexander B Wiltschko. These partnerships have fostered a creative environment that encourages innovation and the sharing of ideas.
Conclusion
John Chan's contributions to facial analysis technology exemplify the spirit of innovation. His patent and ongoing work at Neumora Therapeutics, Inc. highlight his commitment to advancing this field. The impact of his inventions is likely to resonate across multiple industries in the years to come.